Equity Tips

header ads

CAPITALSTARS PRESENTS EQUITY MARKET UPDATE : 18 DEC 2019

INDIAN FACE  
                      
INDIAN EQUITY BENCHMARK
Sensex ended 206.40 points higher or 0.5 percent at 41558.57 while the Nifty gained 56.70 points at 12221.70. M&M, Sun Pharma and Asian Paints are the top gainers while Tata Motors DVR, Tata Motors and YES Bank dragged. The PSU Bank index was the top loser, down over 2 percent while pharma and metal stocks gained. About 1167 shares have advanced, 1292 shares declined, and 211 shares are unchanged.

GLOBAL FACE



Asian Market- Asian markets finished mixed to lower as of the most recent closing prices. Shares in Japan fell as the Nikkei 225 dropped 0.55%. The Shanghai Composite lost 0.18% while the Hang Seng in Hong Kong closed unchanged.  


U.S. Market – North and South American markets finished higher on Tuesday with shares in Brazil leading the region. The Bovespa is up 0.64% while Mexico's IPC is up 0.10% and U.S.'s S&P 500 is up 0.03%.


European markets- European markets are mixed today. The FTSE 100 is up 0.31% while the CAC 40 gains 0.06%. The DAX is off 0.10%.


NIFTY SPOT







MARKET TALKS

TCS up 2% on bagging contract from pet specialty retailer in US
Shares of Tata Consultancy Services (TCS) are trading higher by 2% in afternoon trade after it was selected by Petco, America's leading pet specialty retailer, to deploy TCS Optumera, an Al-powered merchandise optimization suite. TCS Optumera leverages the power of Al and machine learning to localize and right-size store spaces, curate shopper centric omni-channel experiences, anticipate competitor pricing strategies in real-time, and enable optimal price recommendations.  

Alembic Pharma's JV Aleor Derma gets EIR from USFDA
Alembic Pharmaceuticals Ltd (Alembic) informed the exchanges today that Aleor Dermaceuticals Ltd. (Aleor), a 60:40 Joint Venture between the company and Orbicular Pharmaceutical Technologies Pvt. Ltd. (Orbicular), has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the inspection carried out by them at Aleor's Formulation Facility at Karakhadi, Gujarat, India during the period from September 15, 2019 to September 20, 2019. 

Castrol India enters into strategic partnership with Renault; stock down 1%
Shares of Castrol India slipped 1% on the BSE in the late morning trade. The company has entered into a strategic partnership with Renault India Private Limited. Castrol India Limited has entered into a strategic partnership with Renault India Private Limited, under which, Castrol will be Renault India's aftersales engine oil lubricants supplier effective January 1, 2020, and the product range will be available nationally across Renault dealerships.

PC Jeweller slumps over 4% after Sebi slaps Rs8cr on promoters for insider trading
Shares of PC Jeweller slumped over 4% on the BSE after media reports said that Sebi has imposed a total fine of over Rs8cr on Shivani Gupta, Sachin Gupta, Amit Garg and Quick Developers Pvt. Limited for violating insider trading rules in PC Jeweller case. "In light of the alleged violations by Balram Garg, this order shall be treated as a notice calling upon him to show cause as to why direction shall not be passed against him to restrain him from accessing the securities market and prohibiting him from buying, selling or otherwise dealing in securities for an appropriate period," the SEBI order said.

NAME OF THE STOCK : VENKEYS 

DATE : 19/12/2019 

SEGMENT : CASH 

CHART TYPE : Candlestick 

EXCHANGE : NSE 

TECHNICAL INDICATORS USED : VOLUME.MACD, RSI.




INVESTMENT ADVICE:

CALL CS CALL: BUY VENKEYS CASH NR CMP 1727 TGT 1767 SL 1700

RATIONALE FOR ARRIVING INVESTMENT ADVICE : 
THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE.

OTHER REASON IF ANY : SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL


                           DISCLAIMER

The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and upon sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as the only factor while making investment decisions. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets is always subjected to market risk.

CLICK HERE FOR GETTING DETAILS & JOIN OUR BEST ADVISORY  -


CAPITALSTARS CALL US : 9977499927

Derivatives Tips , Intraday Stock Tips , FreeTrading Tips, Sebi Registered advisory 

Post a Comment

0 Comments